Oral Drug Treatment Helps Protect Cancer Patients From Deadly Blood Clots

Oral drug treatment helps protect cancer patients from potentially deadly DVT and pulmonary embolism

• Cancer patients are at high risk of developing blood clots
• Deep vein thrombosis (DVT) and pulmonary embolism (PE) collectively known as venous thromboembolism (VTE), can cause death and disability
• Tablet found to reduce recurrence of VTE

Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition.

People with cancer have an increased risk of developing blood clots, with roughly one in five experiencing venous thromboembolism (VTE) – either deep vein thrombosis (DVT) or pulmonary embolism (PE). Blood clots in the deep veins of the leg may travel to the lungs causing a pulmonary embolism. These two conditions are referred to as VTE – a dangerous and potentially deadly medical condition of which there are 10 million cases worldwide.

To view the full story, please click here.